Search Page

1

Cite

Recent progress on MOF-based optical sensors for VOC sensing.

Shen Y, Tissot A, Serre C. Shen Y, et al. Chem Sci. 2022 Oct 5;13(47):13978-14007. doi: 10.1039/d2sc04314a. eCollection 2022 Dec 7. Chem Sci. 2022. PMID: 36540831 Free PMC article. Review.

Cite

2

Cite

Validation of Cefiderocol Package Insert Dosing Recommendation for Patients Receiving Continuous Renal Replacement Therapy: A Prospective Multicenter Pharmacokinetic Study.

Fouad A, Kobic E, Nicolasora NP, Bastin MLT, Adams PM, Shen Y, Fratoni AJ, Ye X, Kuti JL, Nicolau DP, Asempa TE. Fouad A, et al. Among authors: shen y. Open Forum Infect Dis. 2024 Oct 21;11(10):ofae451. doi: 10.1093/ofid/ofae451. eCollection 2024 Oct. Open Forum Infect Dis. 2024. PMID: 39435320 Free PMC article. Clinical Trial.

Cite

3

Cite

Ex vivo assessment of sulbactam-durlobactam clearance during continuous renal replacement therapy to guide dosing recommendations.

Abouelhassan Y, Shen Y, Chen A, Ye X, Nicolau DP, Kuti JL. Abouelhassan Y, et al. Among authors: shen y. Antimicrob Agents Chemother. 2025 Jan 31;69(1):e0167423. doi: 10.1128/aac.01674-23. Epub 2024 Dec 10. Antimicrob Agents Chemother. 2025. PMID: 39655912 Free PMC article.

Cite

4

Cite

Optimizing antibiotic dosing regimens for nosocomial pneumonia: a window of opportunity for pharmacokinetic and pharmacodynamic modeling.

Shen Y, Kuti JL. Shen Y, et al. Expert Opin Drug Metab Toxicol. 2023 Jan;19(1):13-25. doi: 10.1080/17425255.2023.2178896. Epub 2023 Feb 18. Expert Opin Drug Metab Toxicol. 2023. PMID: 36786064 Review.

Cite

5

Cite

Clinical validation of antimicrobial dosing regimens for continuous renal replacement therapy based on an ex vivo dosing algorithm.

Koenig C, McGrath CP, Roenfanz HF, Shen Y, Monogue ML, Nicolau DP, Kuti JL. Koenig C, et al. Among authors: shen y. J Antimicrob Chemother. 2025 Aug 1;80(8):2269-2279. doi: 10.1093/jac/dkaf199. J Antimicrob Chemother. 2025. PMID: 40576018

Cite

6

Cite

Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration.

Ruiz VH, Shen Y, Abouelhassan Y, Fouad A, Nicolau DP, Kuti JL. Ruiz VH, et al. Among authors: shen y. Am J Health Syst Pharm. 2024 Jan 1;81(1):e21-e29. doi: 10.1093/ajhp/zxad232. Am J Health Syst Pharm. 2024. PMID: 37740370

Cite

7

Cite

Molecular determinants of disease and resistance in interactions of Xanthomonas oryzae pv. oryzae and rice.

Shen Y, Ronald P. Shen Y, et al. Microbes Infect. 2002 Nov;4(13):1361-7. doi: 10.1016/s1286-4579(02)00004-7. Microbes Infect. 2002. PMID: 12443901 Free article. Review.

Cite

8

Cite

Bibliometric Analysis of Research on Exercise Intervention for Cancer-Related Cognitive Impairments.

Shen Y, Xu N, Yu T, Li J. Shen Y, et al. Healthcare (Basel). 2024 Oct 3;12(19):1975. doi: 10.3390/healthcare12191975. Healthcare (Basel). 2024. PMID: 39408155 Free PMC article.

Cite

9

Cite

An ex vivo model to determine transmembrane clearance of antimicrobials during continuous renal replacement therapy.

McGrath C, Koenig C, Roenfanz HF, Shen Y, Nicolau DP, Kuti JL. McGrath C, et al. Among authors: shen y. J Antimicrob Chemother. 2025 Aug 1;80(8):2109-2116. doi: 10.1093/jac/dkaf177. J Antimicrob Chemother. 2025. PMID: 40444723

Cite

10

Cite

One-step synthesis of biofunctional carbon quantum dots for bacterial labeling.

Weng CI, Chang HT, Lin CH, Shen YW, Unnikrishnan B, Li YJ, Huang CC. Weng CI, et al. Biosens Bioelectron. 2015 Jun 15;68:1-6. doi: 10.1016/j.bios.2014.12.028. Epub 2014 Dec 12. Biosens Bioelectron. 2015. PMID: 25557286

Cite